Navigate to
472 Results for GLP-1 Pipeline Update
-
Based on the clinical trial, there are certain expectations for how long patients can anticipate seeing the benefits of treatment. The median duration of response was 11.6 months (95% CI, 4.4 to...
-
This decision to remove REMS comes one year after the FDA loosened REMS requirements and removed the site mandate for CAR T educational and training materials because they deemed the product label...
-
These new solutions reflect Prime's distinctive conflict-free approach to the prescription drug supply chain model.
PA Sub-Categories: Specialty drugs Prime Article: Press Releases -
Pharmacy Friends In the latest episode of the “Pharmacy Friends” podcast, learn the latest insights on legislative trends, cutting-edge drug therapies and more from the 22nd annual event Alex Cook...
PA Sub-Categories: Products Specialty drugs Technology Prime Article: Stories